Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 478,600 | 324,900 | 115,400 | 7,900 | 341,300 |
| Depreciation Amortization | 17,400 | 22,600 | 14,900 | 7,600 | 900 |
| Income taxes - deferred | 165,400 | 117,200 | -51,100 | -13,700 | -123,100 |
| Accounts receivable | -210,500 | -248,900 | -116,600 | -36,900 | -39,800 |
| Other Working Capital | -128,800 | -248,000 | -62,800 | -23,700 | -19,200 |
| Other Operating Activity | 460,600 | 426,500 | 267,000 | 123,600 | 435,300 |
| Operating Cash Flow | $782,700 | $394,300 | $166,800 | $64,800 | $595,400 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,319,800 | -996,800 | -588,300 | -273,200 | -1,056,100 |
| PPE Investments | -34,000 | -36,400 | -23,200 | -10,700 | -38,200 |
| Sale Of Investment | 1,089,400 | 821,700 | 596,700 | 298,100 | 967,500 |
| Investing Cash Flow | $-264,400 | $-211,500 | $-14,800 | $14,200 | $-126,800 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -308,800 |
| Common Stock Issued | 129,400 | 92,100 | 46,500 | 32,100 | 122,100 |
| Common Stock Repurchased | -167,700 | -167,700 | -167,700 | -150,000 | -300,000 |
| Financing Cash Flow | $-38,300 | $-75,600 | $-121,200 | $-117,900 | $-486,700 |
| Exchange Rate Effect | N/A | N/A | 200 | N/A | N/A |
| Beginning Cash Position | 241,000 | 241,000 | 241,000 | 241,000 | 259,100 |
| End Cash Position | 721,000 | 348,200 | 272,000 | 202,100 | 241,000 |
| Net Cash Flow | $480,000 | $107,200 | $31,000 | $-38,900 | $-18,100 |
| Free Cash Flow | |||||
| Operating Cash Flow | 782,700 | 394,300 | 166,800 | 64,800 | 595,400 |
| Capital Expenditure | -34,000 | -36,400 | -23,200 | -10,700 | -38,200 |
| Free Cash Flow | 748,700 | 357,900 | 143,600 | 54,100 | 557,200 |